-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Outperform on IDEAYA Biosciences, Maintains $45 Price Target

Benzinga·11/17/2026 14:37:08
Listen to the news
RBC Capital analyst Leonid Timashev reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $45 price target.